Here are four things to know:
1. Medtronic’s Restorative Therapies Group, inclusive of the spine division, saw global revenue of $1.8 billion for the quarter.
2. The company’s Q3 spine revenue totaled $657 million.
3. Medtronic’s core spine products and bone morphogenetic proteins sector grew in the low single digits.
4. Medtronic spine saw year-over-year revenue growth in every region.
More articles on devices:
Exactech 2016 revenue up 7% to $257.6M: 7 things to know
GS Medical U.S.A. to release several new spine devices — 5 takeaways
5 things to know about Amedica Corp.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
